Foley Partner David Rosen was quoted in an article that appeared in CNNMoney on August 24, 2010 titled “Recall fallout: FDA puts execs on notice.” Rosen discusses increased efforts by the Food and Drug Administration to identify and potentially prosecute executives at companies that have issued a number of recalls due to manufacturing violations. He states that the FDA is developing a tougher compliance attitude because companies are ignoring warnings from the agency, adding that it appears the FDA wants to send a clearer message regarding regulation and compliance.
People
Related News
March 13, 2026
In the News
Chris Babcock and Chris Converse on Wave of Companies Moving to Texas
Foley & Lardner LLP partners Chrisopher Babcock and Chris Converse commented on the widening trend of companies reincorporating to Texas in the Houston Business Journal article, “Texas law changes could spark wave of corporate redomestication proposals."
March 12, 2026
In the News
Louis Lehot Explores M&A's Growing Blitzhire Phenomenon
Foley & Lardner LLP partner Louis Lehot authors article on the emergence of blitzhires in the Mergers & Acquisitions article, “Blitzhires: The New Fast-Moving M&A Deal.”
March 10, 2026
In the News
Aaron Maguregui Shares Insights on Shadow AI Risks in Health Care
Foley & Lardner LLP partner Aaron Maguregui was quoted in the Part B News article, “Do you need AI policy? Experts suggest guardrails as 'shadow AI' spreads,” discussing the emerging risks of unsanctioned 'shadow AI' use by clinicians and the need to establish robust AI governance.